TRPM3 and COVID-19: Indeed, a significant reduction in TRPM3 amplitude after PregS (100 μM) application was shown in freshly isolated NK cells from post-COVID-19 condition participants compared with cells from the HC group (Figure 1G, p < 0.0001).